The Genomic Landscape and Clinical Relevance of A-to-I RNA Editing in Human Cancers. - Wikidata - awgldk - TriplyDB

The Genomic Landscape and Clinical Relevance of A-to-I RNA Editing in Human Cancers.

The Genomic Landscape and Clinical Relevance of A-to-I RNA Editing in Human Cancers.

http://www.wikidata.org/entity/Q36161920

about

A-to-I editing of coding and non-coding RNAs by ADARs ADAR1, inosine and the immune sensing system: distinguishing self from non-self Advances in analyzing RNA diversity in eukaryotic transcriptomes: peering through the Omics lens Functions of the RNA Editing Enzyme ADAR1 and Their Relevance to Human Diseases Rapid and dynamic transcriptome regulation by RNA editing and RNA modifications RNA2DNAlign: nucleotide resolution allele asymmetries through quantitative assessment of RNA and DNA paired sequencing data Complex regulation of ADAR-mediated RNA-editing across tissues Genome-wide analysis of differential RNA editing in epilepsy.Exploring cancer genomic data from the cancer genome atlas project ADAR1 and MicroRNA; A Hidden Crosstalk in Cancer.RED-ML: a novel, effective RNA editing detection method based on machine learning.Single-cell RNA sequencing reveals dynamic changes in A-to-I RNA editome during early human embryogenesis.Optimized approach for Ion Proton RNA sequencing reveals details of RNA splicing and editing features of the transcriptome Altered RNA editing in 3' UTR perturbs microRNA-mediated regulation of oncogenes and tumor-suppressors RNA editing in cancer: Mechanistic, prognostic, and therapeutic implications.LNCediting: a database for functional effects of RNA editing in lncRNAs.Principles Governing A-to-I RNA Editing in the Breast Cancer Transcriptome.Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration.Characterization of RNA editome in primary and metastatic lung adenocarcinomas.Up-regulation of ribosome biogenesis by MIR196A2 genetic variation promotes endometriosis development and progression.Dynamic regulation of RNA editing in human brain development and disease.Gene regulation in the immune system by long noncoding RNAs.Population and allelic variation of A-to-I RNA editing in human transcriptomes.INO80 is required for oncogenic transcription and tumor growth in non-small cell lung cancer.ADAR RNA editing below the backbone.Systematic characterization of A-to-I RNA editing hotspots in microRNAs across human cancers.Identification of human RNA editing sites: A historical perspective.Identification of Diverse Adenosine-to-Inosine RNA Editing Subtypes in Colorectal Cancer.A to I editing in disease is not fake news.RNA editing-dependent epitranscriptome diversity in cancer stem cells.How to stomach an epigenetic insult: the gastric cancer epigenome.Integrating RNA sequencing into neuro-oncology practice.RNA editing generates cellular subsets with diverse sequence within populations.ADAR1 Activation Drives Leukemia Stem Cell Self-Renewal by Impairing Let-7 Biogenesis.Pinin interacts with C-terminal binding proteins for RNA alternative splicing and epithelial cell identity of human ovarian cancer cells.ADAR RNA editing in human disease; more to it than meets the I.CPSF6 is a Clinically Relevant Breast Cancer Vulnerability Target: Role of CPSF6 in Breast Cancer.RNA Editing Dynamically Rewrites the Cancer Code.Metabolomic and Lipidomic Profiling Identifies The Role of the RNA Editing Pathway in Endometrial Carcinogenesis.Protein recoding by ADAR1-mediated RNA editing is not essential for normal development and homeostasis.

P2860

Q26773402-89C463C7-0A03-4226-85C3-8C2C52A49909 Q26773989-CE4DBB22-8F36-4EA4-B989-CE8DFAB0642F Q28068370-E4AF127B-7AB4-4515-9101-E7AC4F12631F Q28078188-096D1203-4599-4034-B9A9-0B375482EFDE Q28078569-5C7F0E3D-6F61-457B-8EE8-8EF53A04CFEF Q28586795-7343C429-F6FB-4180-8660-23DA69008E21 Q28602546-5CA5F56A-9C21-414D-A432-9035FCC8698D Q30840988-BE7554D4-B7EA-498D-982B-9CC079CAC84A Q31121923-C92BF591-4B0E-47F2-B102-E887570BC01D Q33624639-C3CB1155-0300-4FED-B6E0-20A3FFDDADF9 Q33785930-18EC519B-AEC0-4AF0-AAA5-CDEF5186C235 Q36149292-8B0E9CE7-7151-433B-9FC9-E52BA04086CE Q36359621-4E5C8E8C-DD3B-4238-9A8B-AF355F0FF18A Q36690990-04ADE705-484F-481D-B793-8B2738971DBB Q36998031-8BD901C3-EF34-4943-8FC7-8066BC0856F3 Q37556951-71B2EF69-EECF-48AC-AD33-9F956BCAF330 Q37667474-04991FB6-8028-4BEE-88DC-E0E078EA340B Q37684424-D8091C5B-5A4B-4496-AB95-0A86D7F37D6E Q37706941-AF8AFBA3-94E2-4FBE-9077-4D952CADD557 Q37718273-43222EC1-AA55-44A8-A83B-69A37228984C Q38445507-BDDFB698-598A-4E27-B1D1-2A0CF6047480 Q38638798-F4DAF8FD-33B5-4135-A897-3F9C0526A11A Q38654737-9CE13581-6BB2-4AD2-8E0B-91B63718FC58 Q38745550-D872E89B-2D3C-4E05-AF41-4C5641C2C34C Q38755513-DBD7BCB5-1B46-46C3-A9B2-40B527E24A04 Q38836169-49352A1C-2A4C-4330-AC65-2B1FC9FA18AB Q38840611-9766AAAA-0799-45EE-9845-05B2FCD8A8DC Q38978521-AB01FB10-6813-459E-A24B-959706C39DB6 Q39202138-C5F70DB7-0B0B-47B1-96DD-B85B83C1AF8E Q39247132-120688D4-1F4A-49A7-854C-6170F29FCCC5 Q39312802-D08C2A47-C0DD-45E8-B247-193728EDC25E Q39459649-E1355AD5-E8AA-43F1-8EA2-B90893B30C60 Q39600191-88DBBFCD-FF22-4971-8CE7-DB1C824337F3 Q39689950-6F20C2C2-961C-47CE-9089-CADA61D0A1D3 Q40001879-54AE3A5A-64BD-441B-8926-F192E7C99A70 Q40039590-671CA0E9-3C51-406A-919D-139E7781FBC9 Q41041403-B67AEB30-826E-43E6-BA3F-C77646192154 Q41227452-271119E0-AA0C-46B3-B434-EF6A3A7D40CC Q41459821-DFF6C51A-58BC-4AC2-90DB-A87C44381759 Q41625272-68C7BA56-5A75-4B94-89C5-3798F03A8D0E

P2860

The Genomic Landscape and Clinical Relevance of A-to-I RNA Editing in Human Cancers.

http://www.wikidata.org/entity/Q36161920

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

The Genomic Landscape and Clinical Relevance of A-to-I RNA Editing in Human Cancers.

@ast

The Genomic Landscape and Clinical Relevance of A-to-I RNA Editing in Human Cancers.

@en

type

label

The Genomic Landscape and Clinical Relevance of A-to-I RNA Editing in Human Cancers.

@ast

The Genomic Landscape and Clinical Relevance of A-to-I RNA Editing in Human Cancers.

@en

prefLabel

The Genomic Landscape and Clinical Relevance of A-to-I RNA Editing in Human Cancers.

@ast

The Genomic Landscape and Clinical Relevance of A-to-I RNA Editing in Human Cancers.

@en

P1433

Q36161920-3A5E6EAD-4381-4D97-A579-6FE96A74F8E4

P1476

Q36161920-6CF195DD-78E7-4D86-BE56-C386BD748FE9

P2093

Q36161920-03CC544A-03D1-49DE-A0D0-0F99DB94448A

Q36161920-2CE1108C-B769-4A1F-93D1-8C13D249E938

Q36161920-30156529-7D08-4329-B2E4-D743C6548EB2

Q36161920-3BC840B9-B648-44CC-9986-5136F0C5A21D

Q36161920-42B16B87-BCD2-4012-958B-7BC102CD30DC

Q36161920-53F1D9D8-4403-4EFC-A557-DD4244EBEF52

Q36161920-587A0F25-8C27-4209-8679-A2579344BAAA

Q36161920-5DC09B51-C48F-4A53-A34E-8455D82F5B34

Q36161920-63EA39A8-475F-4CD0-9416-33EA4C76BC9F

Q36161920-66C64276-4BBF-43A6-BF79-1DE02D1C3208

P2860

Q36161920-0760699A-152D-4EBE-A2E4-F59BEA22C456

Q36161920-0DB95F9F-39AD-4400-867A-650B6E88FF9F

Q36161920-13D0B1F5-5DB0-4610-BDCB-131678782A98

Q36161920-14F564D9-2289-4885-95B9-017DA7CBE603

Q36161920-15E9BF00-632B-4D56-AFF0-01FAECCC4CA3

Q36161920-1D05732C-5DA8-4AA5-952E-5218A3511063

Q36161920-2B953402-6FB5-482A-A58A-14F9641605B9

Q36161920-335A747E-51B1-49AA-B606-B5DC0CABCC46

Q36161920-494D8290-AA85-4C16-808B-99CFC0ABAE27

Q36161920-4A40F5AA-8E5B-48A9-8F19-2B00637C83FB

P304

Q36161920-F89DA6F3-56CA-4BED-A0A1-6CF799898F17

P31

Q36161920-5306A6F3-308D-42ED-A2D3-69E1526016B4

P356

Q36161920-63B81B17-A2FC-4E2F-8C82-751FF5C22C95

P433

Q36161920-AA6F63D2-A54C-4FAD-B865-B6CF9BBDA02A

P478

Q36161920-F1040B7D-1D54-43A6-8151-B3968F071F87

P50

Q36161920-011D04AB-BBF3-49B4-AFEE-22726E1CDEB5

Q36161920-48746B3F-5880-4EEC-AF25-64A2EAA7F4A0

Q36161920-6DD9C977-9A9F-4A57-AA03-453FDA7EF545

Q36161920-8FD5819F-219E-4DF3-B3B1-68077CE9BE1F

P577

Q36161920-6192AC1C-8CC7-493B-8CEF-506E9E4E1AA3

P5875

Q36161920-F53B46AF-03C3-49DC-A423-DAD57C4A5F17

P698

Q36161920-39B099DE-61F3-4B4E-A3F7-EA07852D5059

P932

Q36161920-84131596-DEA1-4B7B-B96B-982E7AAF804E

P356

J.CCELL.2015.08.013

P1433

P1476

The Genomic Landscape and Clinical Relevance of A-to-I RNA Editing in Human Cancers.

@en

P2093

A Karina Eterovic

http://www.w3.org/2001/XMLSchema#string

Gordon B Mills

http://www.w3.org/2001/XMLSchema#string

Han Liang

http://www.w3.org/2001/XMLSchema#string

Henrica M J Werner

http://www.w3.org/2001/XMLSchema#string

Jie Li

http://www.w3.org/2001/XMLSchema#string

Jin Billy Li

http://www.w3.org/2001/XMLSchema#string

Kang Jin Jeong

http://www.w3.org/2001/XMLSchema#string

Kenneth L Scott

http://www.w3.org/2001/XMLSchema#string

Lixia Diao

http://www.w3.org/2001/XMLSchema#string

Lydia W T Cheung

http://www.w3.org/2001/XMLSchema#string

P2860

A third member of the RNA-specific adenosine deaminase gene family, ADAR3, contains both single- and double-stranded RNA binding domains

Naturally occurring neomorphic PIK3R1 mutations activate the MAPK pathway, dictating therapeutic response to MAPK pathway inhibitors

Down-regulation of RNA editing in pediatric astrocytomas: ADAR2 editing activity inhibits cell migration and proliferation

Underediting of glutamate receptor GluR-B mRNA in malignant gliomas

Q/R site editing in kainate receptor GluR5 and GluR6 pre-mRNAs requires distant intronic sequences

Enabling transparent and collaborative computational analysis of 12 tumor types within The Cancer Genome Atlas

The Cancer Genome Atlas Pan-Cancer analysis project

Comprehensive molecular characterization of human colon and rectal cancer

Comprehensive molecular portraits of human breast tumours

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

P304

515-528

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CCELL.2015.08.013

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-09-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

282593678

http://www.w3.org/2001/XMLSchema#string

P698

26439496

http://www.w3.org/2001/XMLSchema#string

P932

4605878

http://www.w3.org/2001/XMLSchema#string